METRONIDAZOLE 1% / MUPIROCIN 2%- metronidazole 1% / mupirocin 2% ointment 
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

METRONIDAZOLE 1% / MUPIROCIN 2%

Directions for use

ed

Sincerus Florida, LLC. Adverse reactions

dd

Active, inactive

d

NDC 72934- 5143-2 METRONIDAZOLE USP 1% / MUPIROCIN USP 2%. Ointment 30gm

x

METRONIDAZOLE 1% / MUPIROCIN 2% 
metronidazole 1% / mupirocin 2% ointment
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-5143
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
METRONIDAZOLE (UNII: 140QMO216E) (METRONIDAZOLE - UNII:140QMO216E) METRONIDAZOLE1 g  in 100 g
MUPIROCIN (UNII: D0GX863OA5) (MUPIROCIN - UNII:D0GX863OA5) MUPIROCIN2 g  in 100 g
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72934-5143-230 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product05/15/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/15/2019
Labeler - Sincerus Florida, LLC (080105003)
Establishment
NameAddressID/FEIBusiness Operations
Sincerus Florida, LLC080105003manufacture(72934-5143)

Revised: 5/2019
Document Id: 88de7b4e-89f3-7b7d-e053-2a95a90a70b2
Set id: 88de7b4e-89f2-7b7d-e053-2a95a90a70b2
Version: 1
Effective Time: 20190514
 
Sincerus Florida, LLC